drugset / Trial / NCT00347529

Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu

NCT00347529 ↗

Phase 1 Completed 75 enrolled PowderMed
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate how well the vaccine is tolerated at sites where administrations are given, any effects it may have on subjects' wellbeing and whether it can produce antibody responses in the body that may protect against the subjects catching a pandemic strain of flu

Timeline

Start
2006-08
Primary completion
—
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject pPJV2012 Unknown — Other
Subject pPML7789 Unknown — Other

Indications